Anzeige
Mehr »
Login
Montag, 23.09.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Die FED senkt die Zinsen, Gold explodiert: Die eine Aktie, die sie alle überstrahlen könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 940602 | ISIN: NL0000009538 | Ticker-Symbol: PHI1
Tradegate
23.09.24
21:59 Uhr
27,090 Euro
-0,370
-1,35 %
1-Jahres-Chart
KONINKLIJKE PHILIPS NV Chart 1 Jahr
5-Tage-Chart
KONINKLIJKE PHILIPS NV 5-Tage-Chart
RealtimeGeldBriefZeit
27,09027,12022:25
27,10027,14022:00
GlobeNewswire (Europe)
216 Leser
Artikel bewerten:
(1)

Royal Philips: Jackson Health System projects 47% reduction in carbon emissions from patient monitors with Philips next generation monitoring platform

Opportunity for significant savings in energy consumption, reduction of paper and elimination of disposable batteries for telemetry revealed in Life Cycle Assessment

Amsterdam, The Netherlands and Cambridge, Mass. and Miami, FL. -Royal Philips, deployed as an Enterprise Monitoring as a Service*, can help reduce carbon emissions by 685.1 tons of CO2e or 47% compared to previous systems [1,2,3]. This significant reduction also eliminates the need for an estimated 420,000 disposable AA batteries and 6.5 million sheets of paper, which can allow the health system to save $1.2 million over a 10-year device lifetime. These findings suggest that patient monitoring can become part of an overall carbon reduction strategy for health systems.

Data from the LCA indicates that the Philips IntelliVue and EarlyVue monitors can help reduce the health system's patient monitoring carbon footprint by 508 tons of CO2e across all facets of the lifecycle. Battery and paper savings reduce CO2e by an additional 177.1 tons [2,3]. Before upgrading to Philips, all of Jackson's legacy telemetry patient monitors were powered by disposable AA batteries, requiring hundreds of replacements each week. With the previous monitors, clinicians printed paper wavestrips multiple times a day per patient and then manually scanned them into their electronic medical record. In contrast, Philips telemetry monitors can run on rechargeable batteries, and provide a digital, automated wavestrip workflow, eliminating paper waste and freeing clinicians to spend more time with patients.

"At Jackson Health System, we are committed to sustainable practices that support human and environmental health," said Rosa M. Costanzo, Chief Supply Chain and Procurement Officer at Jackson Health System. "By transitioning to Philips patient monitors, we can reduce our carbon footprint and bring lasting benefits in materials and costs. This assessment illustrates that health systems can balance the need for advanced technology with environmental sustainability."

Jackson Health System prioritizes sustainable procurement practices and is deliberate with the lifecycle of its technology. The healthcare provider has traded in its legacy monitors to AllParts Medical, a division of Philips, for parts refurbishment and reuse, responsible recycling and to promote circularity to ensure nothing is sent to landfill. The health system has also been working with a partner to recycle 100% of its paper and batteries.

"There are significant sustainability challenges in today's healthcare industry, and forward-thinking health systems are taking action," said Jeff DiLullo, Chief Region Leader, Philips North America. "I commend Jackson Health System for leading by example and embracing sustainable digital capabilities. By integrating advanced technology to reduce carbon emissions and cut waste, they create the benefit of improving staff satisfaction and productivity. Together, we can pave the way to better patient care while also protecting our planet with a healthier, more sustainable future."

The LCA was conducted using data collection, onsite interviews and analysis to quantify costs and waste figures. The LCA evaluated 2,887 bedside, telemetry, transport and spot-check monitors from production to disposal, assessing environmental impacts of resource extraction, manufacturing, transportation, use and end of use.

[1] Results from case studies are not predictive of results in other cases.
[2] Life Cycle Assessment (LCA) results are obtained using Philips Environmental Profit & Loss (EP&L), proxy data, and literature and estimated data. The LCA is not validated externally by 3rd party.
[3] The outcomes are projected over the device's lifespan.

*Philips and Jackson Health have been long-term, strategic partners since 2018 around an Enterprise Monitoring as a Service(EMaaS) model. EMaaS is a subscription-based solution that provides healthcare organizations with integrated patient monitoring technology and services to enhance patient care and streamline hospital operations.

Contact:
Avi Dines
Philips North America
Tel: +1-781-690-3814
Email: avi.dines@philips.com

Joost Maltha
Philips External Relations
Tel: +31 6 10 55 8116
Email: joost.maltha@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 68,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

About Jackson Health System
Jackson Health System is one of the nation's largest and most respected public health systems, with a mission of providing one standard of high quality care to all residents of Miami-Dade County. The nonprofit academic medical system is anchored by Jackson Memorial Hospital, which is home to Ryder Trauma Center and the Miami Transplant Institute. The system also includes Holtz Children's Hospital/The Women's Hospital at Jackson Memorial, Jackson Behavioral Health Hospital, Christine E. Lynn Rehabilitation Center for The Miami Project to Cure Paralysis at UHealth/Jackson Memorial, Jackson North Medical Center, Jackson South Medical Center, Jackson West Medical Center, multiple primary care and specialty care centers, a network of UHealth Jackson Urgent Care centers, physician practices, two long-term care nursing facilities, and a network of mental health facilities.


Attachments

  • Jackson Memorial Health System (https://ml-eu.globenewswire.com/Resource/Download/a453c296-fb43-481f-9976-05822498628e)
  • Philips MX550 IntelliVue Portable Bedside Patient Monitor with Shield (https://ml-eu.globenewswire.com/Resource/Download/a15995b8-1323-4dad-92a2-3e2a6c609f8f)
  • Philips MX750, MX850, IntelliVue, Patient Monitors with Shield (https://ml-eu.globenewswire.com/Resource/Download/0444c0ca-e8a7-44da-89e0-7c4fe1a46564)

© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.